Effective Dose for Selection of DAT and Amyloid Imaging Agents, as Well as 18F-FDG
| Agent | Effective dose per injected activity (μSv/MBq) | Injected activity (MBq) | Bladder-voiding interval (h) | Effective dose*(mSv) |
| 18F-FE-PE2I | 23 | 200 | 3.5 | 4.6 |
| 20 | 200 | 1 and 2 | 4.0 | |
| 18F-FE-PE2I (primates) (10) | 21 | 200 | 4.8 | 4.2 |
| 11C-PE2I (22) | 6.4 | 222 | — | 1.4 |
| 123I-FP-CIT (20) | 25 | 185 | 3.5 | 4.6 |
| 11C-PiB (23) | 5.3 | 555 | 2.4 | 2.9 |
| 18F-AV-45 (24) | 18 | 370 | 2.4 | 6.7 |
| 18F-GE067 (25) | 34 | 185 | 2 | 6.3 |
| 18F-BAY94–9172 (23) | 15 | 300 | 2.4 | 4.5 |
| 18F-FDG (20) | 19 | 280 | 3.5 | 5.3 |
↵* Calculated using activity recommended for 70-kg person.